Earnings Call · Q2 FY2021·2021-07-28

Q2 21EPS -6.35%·Rev n/aQ1 21EPS +3.28%·Rev n/aQ4 20EPS +7.94%·Rev n/aQ3 20EPS -1.69%·Rev n/a⚠ consensus missing

TEVA PHARMACEUTICAL INDUSTRIES LTD TEVJF

Kevin Mannix — Investor Relations or Communications

Kåre Schultz — Chief Executive Officer

Eli Kalif — Chief Financial Officer

+4.8%1d on move date+4.9% vs SPY3d−0.6%5d−0.6%

Research tier

Behavioral profile computed for 3 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more TEVJF calls or request research access.

More TEVJF calls Browse calls Request research access